glp 1 sexual side effects Sex Drive, Erectile Dysfunction, and GLP-1 GLP-1s for Weight Loss: What

Mistake 1: Gel packs directly touching the medication This freezes the medication

health insurance claims data for more than 50 million people from 2022-2024 and determined that, after an initial jump in spending related to the start of injectable GLP-1 drugs like Ozempic (NVO) and Wegovy, cost growth for the treatment group trended at half the rate of a control group in the second year

Novo Nordisk announced that the FDA accepted a new drug application for a 25 mg oral version of semaglutide (Wegovy) for two new indications: Chronic weight management in adults living with obesity or who are overweight with at least one comorbid condition Reduce the risk of major adverse cardiovascular events (MACE) in adults with obesity or overweight with established cardiovascular disease (CVD)

Two honest caveats

Effects of Once-Daily Oral Orforglipron on Weight and Metabolic Markers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

The companies say that in small doses the drugs can provide myriad health benefits, but as Katie Palmer reports, theres no robust evidence of these marketing claims